ID |
Status |
Summary |
43
|
New |
Migrate this repo to github
Type-Enhancement
Priority-Medium
|
42
|
New |
biological vector role
Type-Enhancement
Priority-Medium
|
41
|
Done |
this is a test
Type-Clarification
Priority-Medium
|
40
|
Done |
label for asymptomatic host of infections agent reads "aymptomatic..."
Type-Enhancement
Priority-Medium
|
39
|
New |
The IDO homepage has a link to 'funny love quotes' coming off of the text under "Consortium"
Type-Defect
Priority-Medium
|
38
|
New |
Browse IDO link is broken
Type-Defect
Priority-Medium
|
37
|
Accepted |
Antibiotic too narrow
Type-Defect
Priority-Medium
|
36
|
New |
Multiple definitions and labels for TRANS_0000000
Type-Defect
Priority-Medium
|
35
|
Done |
rate, incidence, etc
Type-Defect
Priority-Medium
|
34
|
Done |
extra label for transmission process
Type-Enhancement
Priority-Medium
|
33
|
Done |
New term : seroprevalence
Type-Enhancement
Priority-Medium
|
32
|
Done |
acquired immunity and adpative immunity
Type-Defect
Priority-Medium
|
31
|
New |
new term: seroprotection
Type-Enhancement
Priority-Medium
|
30
|
Done |
term "infection incidence rate" & "infection incidence proportion"
Type-Enhancement
Priority-Medium
|
29
|
New |
object properties metadata
Type-Enhancement
Priority-Medium
|
28
|
Done |
host role
Type-Enhancement
Priority-Medium
|
27
|
Done |
new term: drug resistance
Type-Enhancement
Priority-Medium
|
26
|
Done |
GO terms with wrong URI
Type-Defect
Priority-Medium
|
25
|
Done |
virion
Type-Clarification
Priority-Medium
|
24
|
Done |
term submission: host identifier
Type-Term
Priority-Medium
|
23
|
Done |
test issue for debugging tracker mailing list
Type-Clarification
Priority-Medium
|
22
|
Done |
IEDB terms
Project-IDO
Type-Term
Priority-Medium
|
21
|
Done |
infection
Type-Enhancement
Priority-Medium
|
20
|
Done |
vaccination import ?
Type-Enhancement
Priority-Medium
|
19
|
Done |
host role - relabel
Priority-Medium
|
18
|
Started |
infectious agent - organisms only
Type-Enhancement
Priority-Medium
|
17
|
Done |
symptom/sign
Project-IDO
Type-Comment
Priority-Medium
|
16
|
Done |
GDCs: representation and normal value
Type-Comment
Priority-Medium
Project-IDO
|
15
|
WontFix |
virulence
Type-Clarification
Priority-Medium
|
14
|
Done |
asserted subclasses of fiat_object_part, object, object_aggregate
Project-IDO
Type-Comment
Priority-Medium
|
13
|
Done |
defined classes are not defined
Type-Enhancement
Priority-Medium
|
12
|
Done |
documentation pattern "disposition -> role -> material"
Project-IDO
Type-Comment
Priority-Medium
|
11
|
Done |
duplication in OWL file + BFO Capability
Type-Enhancement
Priority-Medium
|
10
|
Done |
_defined_hierarchy
Type-Enhancement
Priority-Medium
|
9
|
Done |
Find reference to paper that describes or implies that there is a signaling with direct consequent inhibition to turn it off
Project-Pathways
Type
|
8
|
Done |
Review GO and see if they describe cellular process that include both signaling and consequent inhibition to time it
Project-Pathways
Priority-High
|
7
|
Done |
inhibition and signaling feedback/ competitive binding
Project-Pathways
Priority-High
|
6
|
Done |
Classes of complexes such as NFKB, and representation of more specific types in processes
Type-Documentation
Priority-Medium
|
5
|
Done |
location of process and participants
Type-Documentation
Priority-Medium
|
4
|
Done |
Complex disassembly - how to link to GO, PATO?
Project-Pathways
Priority-Medium
|
3
|
Done |
Representation of transcription factor binding leading to production of gene product
Project-Pathways
Priority-Medium
|
2
|
Done |
How to represent that a domain is not accessible to interact with and then becomes accessible
Project-Pathways
Priority-Medium
|
1
|
Done |
How to write that degradation has happened
Type-Enhancement
Priority-Medium
|